THIRD HARMONIC BIO
Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, oral KIT inhibitor for treatment of severe allergy and inflammation. KIT is a cell surface receptor that acts as the master survival and functional regulator of mast cells, which are immune cells concentrated at the body’s interfaces with the external environment and that act as the key mediator of the inflammation associated with allergic diseases.
THIRD HARMONIC BIO
Industry:
Biotechnology Life Science
Founded:
2019-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.thirdharmonicbio.com
Total Employee:
11+
Status:
Active
Total Funding:
155 M USD
Similar Organizations
ALX Oncology
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Advisors List
Current Employees Featured
Investors List
Boxer Capital
Boxer Capital investment in Series B - Third Harmonic Bio
RTW Investments LLC
RTW Investments LLC investment in Series B - Third Harmonic Bio
General Atlantic
General Atlantic investment in Series B - Third Harmonic Bio
BVF Partners
BVF Partners investment in Series B - Third Harmonic Bio
Ajax Health
Ajax Health investment in Series B - Third Harmonic Bio
RA Capital Management
RA Capital Management investment in Series B - Third Harmonic Bio
Commodore Capital
Commodore Capital investment in Series B - Third Harmonic Bio
Deep Track Capital
Deep Track Capital investment in Series B - Third Harmonic Bio
BVF Partners
BVF Partners investment in Series A - Third Harmonic Bio
OrbiMed
OrbiMed investment in Series A - Third Harmonic Bio
Key Employee Changes
Date | New article |
---|---|
2022-06-06 | Third Harmonic Bio Appoints Edward R. Conner, M.D., as Chief Medical Officer |
2022-03-09 | Third Harmonic Bio Appoints Robert Ho as Chief Financial Officer |
Official Site Inspections
http://www.thirdharmonicbio.com Semrush global rank: 3.67 M Semrush visits lastest month: 3.84 K
- Host name: 113.243.231.35.bc.googleusercontent.com
- IP address: 35.231.243.113
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York